Evidence map›Paper›PMID 38033994›Full record

ArticleFrontiers in endocrinology2023

Effect of hyperlipidemia on the outcome of

Fang Yang, Jin-Chun Lu, Tao Shen, Yi-Han Jin, Yuan-Jiao Liang

Open access · goldAbstract read
In one paragraph

Article in Frontiers in endocrinology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 9 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 3 countries.

Fang YangCenter for Reproductive Medicine, Zhongda Hospital, Southeast University, Nanjing, Jiangsu, China.
Jin-Chun LuCenter for Reproductive Medicine, Zhongda Hospital, Southeast University, Nanjing, Jiangsu, China.
Tao ShenCenter for Reproductive Medicine, Zhongda Hospital, Southeast University, Nanjing, Jiangsu, China.
Yi-Han JinCenter for Reproductive Medicine, Zhongda Hospital, Southeast University, Nanjing, Jiangsu, China.
Yuan-Jiao LiangCenter for Reproductive Medicine, Zhongda Hospital, Southeast University, Nanjing, Jiangsu, China.
Zhongda Hospital Southeast University · CNCenters for Disease Control and Prevention · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: It is little known whether hyperlipidemia alone has adverse effects on the outcome of Methods: The PCOS patients with body mass index (BMI) < 30 kg/m Results: In the fresh cycles, total gonadotropin dosage in the control group was significantly lower than that in the hyperlipidemia group, and serum estradiol levels on trigger day were reversed ( Conclusion: Hyperlipidemia may increase the dosage of gonadotropin and have adverse effect on the embryo quality, endometrial receptivity, and clinical outcomes of lean PCOS patients. It is recommended that the non-obese patients with hyperlipidemia and PCOS perform lipid-lowering treatment before undergoing embryo transfer.

Indexed as

HyperlipidemiasPolycystic Ovary SyndromeEstradiolFemaleFertilization in VitroGonadotropinsHumansMalePregnancyPregnancy RateSemenEstradiolGonadotropinshyperlipidemiain vitro fertilizationnon-obesepolycystic ovary syndromepregnancy outcome

Identifiers

PMID38033994
PMCPMC10682775
OpenAlexW4388655906

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.